189 related articles for article (PubMed ID: 25301808)
21. A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers.
Kim SC; Jung Y; Park J; Cho S; Seo C; Kim J; Kim P; Park J; Seo J; Kim J; Park S; Jang I; Kim N; Yang JO; Lee B; Rho K; Jung Y; Keum J; Lee J; Han J; Kang S; Bae S; Choi SJ; Kim S; Lee JE; Kim W; Kim J; Lee S
PLoS One; 2013; 8(2):e55596. PubMed ID: 23405175
[TBL] [Abstract][Full Text] [Related]
22. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
24. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
25. Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.
Hsu MK; Wu IC; Cheng CC; Su JL; Hsieh CH; Lin YS; Chen FC
Oncotarget; 2015 Oct; 6(30):28755-73. PubMed ID: 26356813
[TBL] [Abstract][Full Text] [Related]
26. Integrative transcriptome analysis identifies deregulated microRNA-transcription factor networks in lung adenocarcinoma.
Cinegaglia NC; Andrade SC; Tokar T; Pinheiro M; Severino FE; Oliveira RA; Hasimoto EN; Cataneo DC; Cataneo AJ; Defaveri J; Souza CP; Marques MM; Carvalho RF; Coutinho LL; Gross JL; Rogatto SR; Lam WL; Jurisica I; Reis PP
Oncotarget; 2016 May; 7(20):28920-34. PubMed ID: 27081085
[TBL] [Abstract][Full Text] [Related]
27. PenDA, a rank-based method for personalized differential analysis: Application to lung cancer.
Richard M; Decamps C; Chuffart F; Brambilla E; Rousseaux S; Khochbin S; Jost D
PLoS Comput Biol; 2020 May; 16(5):e1007869. PubMed ID: 32392248
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional maturation of the mouse auditory forebrain.
Hackett TA; Guo Y; Clause A; Hackett NJ; Garbett K; Zhang P; Polley DB; Mirnics K
BMC Genomics; 2015 Aug; 16(1):606. PubMed ID: 26271746
[TBL] [Abstract][Full Text] [Related]
29. RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients.
Zhang Q; Hu H; Liu H; Jin J; Zhu P; Wang S; Shen K; Hu Y; Li Z; Zhan P; Zhu S; Fan H; Zhang J; Lv T; Song Y
Biomed Pharmacother; 2018 Sep; 105():204-214. PubMed ID: 29857300
[TBL] [Abstract][Full Text] [Related]
30. Towards a PBMC "virogram assay" for precision medicine: Concordance between ex vivo and in vivo viral infection transcriptomes.
Gardeux V; Bosco A; Li J; Halonen MJ; Jackson D; Martinez FD; Lussier YA
J Biomed Inform; 2015 Jun; 55():94-103. PubMed ID: 25797143
[TBL] [Abstract][Full Text] [Related]
31. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
[TBL] [Abstract][Full Text] [Related]
32. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
33. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
[TBL] [Abstract][Full Text] [Related]
34. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
35. Evaluating single-subject study methods for personal transcriptomic interpretations to advance precision medicine.
Rachid Zaim S; Kenost C; Berghout J; Vitali F; Zhang HH; Lussier YA
BMC Med Genomics; 2019 Jul; 12(Suppl 5):96. PubMed ID: 31296218
[TBL] [Abstract][Full Text] [Related]
36. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples.
Hintzsche J; Kim J; Yadav V; Amato C; Robinson SE; Seelenfreund E; Shellman Y; Wisell J; Applegate A; McCarter M; Box N; Tentler J; De S; Robinson WA; Tan AC
J Am Med Inform Assoc; 2016 Jul; 23(4):721-30. PubMed ID: 27026619
[TBL] [Abstract][Full Text] [Related]
37. Pathway-based identification of a smoking associated 6-gene signature predictive of lung cancer risk and survival.
Guo NL; Wan YW
Artif Intell Med; 2012 Jun; 55(2):97-105. PubMed ID: 22326768
[TBL] [Abstract][Full Text] [Related]
38. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.
Robles AI; Arai E; Mathé EA; Okayama H; Schetter AJ; Brown D; Petersen D; Bowman ED; Noro R; Welsh JA; Edelman DC; Stevenson HS; Wang Y; Tsuchiya N; Kohno T; Skaug V; Mollerup S; Haugen A; Meltzer PS; Yokota J; Kanai Y; Harris CC
J Thorac Oncol; 2015 Jul; 10(7):1037-48. PubMed ID: 26134223
[TBL] [Abstract][Full Text] [Related]
39. Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
Kikutake C; Yahara K
PLoS One; 2016; 11(4):e0152918. PubMed ID: 27042856
[TBL] [Abstract][Full Text] [Related]
40. Curation-free biomodules mechanisms in prostate cancer predict recurrent disease.
Chen JL; Hsu A; Yang X; Li J; Lee Y; Parinandi G; Li H; Lussier YA
BMC Med Genomics; 2013; 6 Suppl 2(Suppl 2):S4. PubMed ID: 23819917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
